Difficulty: Medium
Average Score: 82%
Practice
A 34-year-old patient who is 16 weeks pregnant had a multiple markers screening done. The results came back with an increased risk for trisomy 21. You call the patient to go over the results. How should you respond when the patient asks you if the baby is going to have Down syndrome?
Correct answer
B
Rationale
In this scenario, option B is the correct response. As a healthcare provider discussing prenatal screening results with a patient, it is crucial to provide accurate information and clarify the limitations of the screening tests. By choosing option B, you are appropriately informing the patient that the multiple markers screening only assesses the risk for Down syndrome and does not provide a definitive diagnosis. This allows the patient to understand the need for further diagnostic testing to confirm the presence of the condition.
Option A is incorrect as it presents a biased and non-informative approach by immediately jumping to the topic of pregnancy continuation or termination without providing necessary context or information. Option C is also incorrect as it deflects the responsibility of discussing the results from the healthcare provider to the patient's next appointment, potentially causing unnecessary anxiety for the patient. Option D is incorrect as it provides a premature and definitive diagnosis without emphasizing the need for confirmatory testing.
From an educational perspective, this question highlights the importance of clear communication and patient education in the field of pharmacology, specifically in prenatal screening and genetic testing. It emphasizes the need for healthcare providers to deliver information in a sensitive and accurate manner, ensuring that patients understand the implications of screening results and the next steps in their care.
Option A is incorrect as it presents a biased and non-informative approach by immediately jumping to the topic of pregnancy continuation or termination without providing necessary context or information. Option C is also incorrect as it deflects the responsibility of discussing the results from the healthcare provider to the patient's next appointment, potentially causing unnecessary anxiety for the patient. Option D is incorrect as it provides a premature and definitive diagnosis without emphasizing the need for confirmatory testing.
From an educational perspective, this question highlights the importance of clear communication and patient education in the field of pharmacology, specifically in prenatal screening and genetic testing. It emphasizes the need for healthcare providers to deliver information in a sensitive and accurate manner, ensuring that patients understand the implications of screening results and the next steps in their care.